SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615219-20-000075
Filing Date
2020-06-22
Accepted
2020-06-22 17:16:22
Documents
2
Period of Report
2020-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159286056084451.html 3  
1 FORM 3 wf-form3_159286056084451.xml 3 1743
2 EX-24 DOCUMENT JL1 salarius-section16powerofa3.htm EX-24 10582
  Complete submission text file 0001615219-20-000075.txt   13824
Mailing Address C/O HISTOGENICS CORPORATION 830 WINTER STREET #3 WALTHAM MA 02451
Business Address
Lieber Jonathan I (Reporting) CIK: 0001350090 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 20979585

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences